1. PROTAC Vitamin D Related/Nuclear Receptor Apoptosis
  2. Molecular Glues Androgen Receptor Caspase Apoptosis
  3. AR Degrader-3

AR Degrader-3 一种具有口服活性的分子胶 (molecular glue),靶向 AR/ARV7, 通过泛素-蛋白酶体途径 (UPP) 诱导 ARARV7 降解。AR Degrader-3 可直接与 AR 的配体结合域 (LBD) 和 N 端结构域 (NTD) 相互作。AR Degrader-3 能有效抑制野生型 AR (AR-WT)、AR 突变体和 ARV7 的转录活性。AR Degrader-3 可下调下游 AR 靶基因的 mRNA 和蛋白水平,从而克服由 ARV7 和 AR 点突变介导的抗雄激素耐药性。AR Degrader-3 可诱导 Enzalutamide (HY-70002) (ENZa) 耐药细胞凋亡 (apoptosis),并增加裂解型 caspase-3 蛋白的水平。AR Degrader-3 可用于去势抵抗性前列腺癌 (CRPC) 的研究。

MCE 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务

AR Degrader-3

AR Degrader-3 Chemical Structure

CAS No. : 1182011-65-9

1.  客户无需承担相应的运输费用。

2.  同一机构(单位)同一产品试用装仅限申领一次,同一机构(单位)一年内

     可免费申领三个不同产品的试用装。

3.  试用装只面向终端客户

规格 是否有货
50 mg   询价  
100 mg   询价  
250 mg   询价  

* Please select Quantity before adding items.

Customer Review

  • 生物活性

  • 纯度 & 产品资料

  • 参考文献

生物活性

AR Degrader-3 is an orally active molecular glue that targets AR/ARV7 and induces the degradation of AR and ARV7 through the ubiquitin-proteasome pathway (UPP). AR Degrader-3 directly interacts with the ligand-binding domain (LBD) and the N-terminal domain (NTD) of AR. AR Degrader-3 effectively suppresses the transcriptional activity of wild-type AR (AR-WT), AR mutants, and ARV7. AR Degrader-3 downregulates the mRNA and protein levels of downstream AR target genes, thereby overcoming antiandrogen resistance mediated by ARV7 and AR point mutations. AR Degrader-3 induces apoptosis in Enzalutamide (HY-70002) (ENZa)-resistant cells and increases cleaved caspase-3 protein levels. AR Degrader-3 can be used for the study of castration-resistant prostate cancer (CRPC)[1].

IC50 & Target

Caspase-3

 

体外研究
(In Vitro)

AR Degrader-3 (Compound A6) (0.2-5 μM,24 小时) 通过剂量依赖性地抑制 PC-3 和 C4-2 细胞中外源性和内源性 AR 的表达,从而广泛抑制 AR 的转录活性;此外,它还显著抑制了 Enzalutamide 耐药的 22Rv1 细胞中的内源性 AR 和 ARV7 的表达,并抑制了 PC-3 细胞中 AR 突变体 (W741L、T877A、F876L) 的转录活性[1]
AR Degrader-3 (0.078-10 μM,0-36 小时) 以剂量依赖性的方式抑制 22Rv1 细胞中 ARV7 的蛋白水平 (DC50 = 0.24 μM) ,显著下调 C4-2 细胞中 AR 的蛋白水平 (DC50 = 0.18 μM) ,并以时间依赖性的方式下调 ARV7 的蛋白水平[1]
AR Degrader-3 能有效抑制 LNCaP 细胞中的 AR 和 ARV7,其机制是通过直接结合 AR-LBD (IC50 = 105.4 nM) 和 AR-AF1 (KD = 23.0 μM)[1]
AR Degrader-3 (1-5 μM,4-8 小时) 通过泛素-蛋白酶体途径 (UPP) 降解 AR 和 ARV7,体现在 C4-2 和 22Rv1 细胞中,AR Degrader-3 分别剂量依赖性地降低 AR 和 ARV7 的蛋白水平 (而非 mRNA 水平) ;环己酰亚胺处理可加速 AR 和 ARV7 的降解;MG132 可拮抗 AR Degrader-3 的蛋白水平降低作用;以及 AR Degrader-3 显著诱导 AR 的泛素化[1]
AR Degrader-3 (72 小时) 抑制 C4-2 细胞 (IC50 = 0.59 μM) 和 22Rv1 细胞 (IC50 = 1.4 μM) 的增殖,但对 DU145 细胞 (IC50 > 50 μM) 和 PC-3 细胞 (IC50 = 48.6 μM) 的影响甚微[1]
AR Degrader-3 (0.2-5 μM,8-24 小时) 以剂量依赖的方式阻断 R1881 诱导的 PSA 蛋白表达,并降低 22Rv1 细胞中 PSA 和 PMEPA1 的 mRNA 水平[1]
AR Degrader-3 (1-2 μM,14 天) 选择性地减少 22Rv1 细胞的克隆形成数量,但对 AR 阴性的 PC-3 细胞的克隆形成数量没有影响,并促进 22Rv1 细胞的凋亡[1]

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Western Blot Analysis[1]

Cell Line: 22Rv1 cells
Concentration: 5 μM
Incubation Time: 24 h
Result: Significantly downregulated the level of ARV7.

Western Blot Analysis[1]

Cell Line: 22Rv1 cells, C4-2 cells
Concentration: 0.078 μM, 0.156 μM, 0.31 μM, 0.62 μM, 1.25 μM, 2.5 μM, 5 μM, 10 μM
Incubation Time: 24 h
Result: Dose-dependently suppressed ARV7 (DC50 = 0.24 μM) protein level in 22Rv1 cells, down-regulated AR (DC50 = 0.18 μM) protein level in C4-2 cells.

Western Blot Analysis[1]

Cell Line: 22Rv1 cells
Concentration: 0.2 μM, 1 μM, 5 μM
Incubation Time: 24 h
Result: Blocked R1881-induced PSA protein expression in a dose-dependent manner in 22Rv1 cells.

RT-PCR[1]

Cell Line: 22Rv1 cells
Concentration: 0.2 μM, 1 μM, 5 μM
Incubation Time: 8 h
Result: Reduced the mRNA level of PSA in 22Rv1 cells.

RT-PCR[1]

Cell Line: 22Rv1 cells
Concentration: 0.2 μM, 1 μM, 5 μM
Incubation Time: 24 h
Result: Reduced the mRNA level of PMEPA1 in 22Rv1 cells.

Cell Proliferation Assay[1]

Cell Line: 22Rv1 cells, PC-3 cells
Concentration: 1 μM, 2 μM
Incubation Time: 14 days
Result: Decreased 22Rv1 cells colony numbers but showed no influence on AR-negative PC-3 cells colony numbers.
体内研究
(In Vivo)

AR Degrader-3 (Compound A6) (15-30 mg/kg,口服,每日一次,持续 14 天) 可有效抑制 22Rv1 细胞荷瘤小鼠体内 CRPC 肿瘤的生长,且未观察到明显的毒性[1]

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: Male BALB/c nude mice (5-week-old) were subcutaneously inoculated with 5 × 106 22Rv1 cells[1].
Dosage: 15 mg/kg, 30 mg/kg
Administration: P.o., once daily for 14 days
Result: Suppressed 22Rv1 tumor progression.
Showed no change in body weight.
Significantly decreased AR levels in the tumor tissues.
分子量

435.50

Formula

C23H21N3O4S

CAS 号
运输条件

Room temperature in continental US; may vary elsewhere.

储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.

纯度 & 产品资料
参考文献
  • 摩尔计算器

  • 稀释计算器

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

质量   浓度   体积   分子量 *
= × ×

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

浓度 (start) × 体积 (start) = 浓度 (final) × 体积 (final)
× = ×
C1   V1   C2   V2
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

您最近查看的产品:

Your information is safe with us. * Required Fields.

   产品名称:

 

* 需求量:

* 客户姓名:

 

* Email:

* 电话:

 

* 公司或机构名称:

   留言给我们:

Bulk Inquiry

Inquiry Information

产品名称:
AR Degrader-3
目录号:
HY-178938
需求量: